3LU-13766-09088
3 vaccinations
3 coded responses
15 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 221 / VA
- Registered
- 2021-08-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-31
Dose 1 — Pfizer-BioNTech
-
2021-02-28
Dose 2 — Pfizer-BioNTech
-
2021-08-21
Registered in v-safe
-
2021-08-21
Dose 3 — Pfizer-BioNTech
- 2021-08-21
-
2021-08-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-08-23
- 2021-08-24
-
2021-08-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-08-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-08-28
Survey response — day 7, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Fibromyalgia flareMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-04
- 2021-09-11
- 2021-09-18
-
2021-09-25
Survey response — day 35, dose 3MedDRA: Asthenia, Balance disorder, Body temperature increased, Chills, Decreased appetite, Headache, Lethargy, Myalgia, Nausea, Night sweats, Office visit, Oropharyngeal pain, Restless arm syndrome, Restless legs syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Sore throat, nonstop headache, extreme lethargy, zero energy, slight fever 99.5, night sweats, chills, muscle aches, restless arms & legs, off balance, nausea, lack of appetite 9/19-present. Had direct exposure for 4 consecutive days · Healthcare visit (other): Two In person appointments with PCPMedDRA releases: 2024-11 · check-in free text available
-
2021-09-25
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-30
- 2021-10-02
- 2021-11-03
-
2021-11-03
Call successfulParticipant prefers to complete VAERS report online
- 2021-11-20
- 2022-02-19
-
2022-08-21
Survey response — 12 months, dose 3MedDRA: COVID-19, Nasopharyngitis, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Had Covid on June 12, approximately 2 weeks after my 2nd booster. Felt like a bad head cold, got Paxlovid and it helped a lot! · Healthcare visit (other): PCP visitMedDRA releases: 2024-11 · check-in free text available
-
2022-08-21
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-08-22
- 2022-08-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-31 | Pfizer-BioNTech | No |
| 2 | 2021-02-28 | Pfizer-BioNTech | No |
| 3 | 2021-08-21 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 9 — day 7, dose 3
Systemic reaction (other): Fibromyalgia flare
Release 9 — day 35, dose 3
Symptoms: Sore throat, nonstop headache, extreme lethargy, zero energy, slight fever 99.5, night sweats, chills, muscle aches, restless arms & legs, off balance, nausea, lack of appetite 9/19-present. Had direct exposure for 4 consecutive days
Healthcare visit (other): Two In person appointments with PCP
Release 12 — 12 months, dose 3
Symptoms: Had Covid on June 12, approximately 2 weeks after my 2nd booster. Felt like a bad head cold, got Paxlovid and it helped a lot!
Healthcare visit (other): PCP visit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Balance disorder | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Restless arm syndrome | · | · | ✓ |
| SD | Restless legs syndrome | · | · | ✓ |
| SRO | Condition aggravated | ✓ | · | ✓ |
| SRO | Pre-existing disease | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release